The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9 Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006
Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004
MMP-7 / MMP-9 in stable lung transplant recipients - a potential role in obliterative bronchiolitis Source: Eur Respir J 2003; 22: Suppl. 45, 202s Year: 2003
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008
Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003
IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 465s Year: 2004
Forced oscillometry for early detection of bronchiolitis obliterans (BO) following hematogenous stem cell transplant (HSCT) Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018
Towards a model of bronchiolitis obliterans syndrome in single lung transplanted mice Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010
Hepatocyte growth factor (HGF) in lung allografts Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS) Source: Eur Respir J 2006; 28: Suppl. 50, 120s Year: 2006
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011
Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients? Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Neutrophils and IL-8 in low airway in children with bronchiolitis obliterans (BO) and severe asthma (SA) Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004
Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004
Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005